B
United Therapeutics Corporation UTHR
$307.24 $1.850.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 19.72% 22.89% 19.85% 33.70% 25.07%
Total Other Revenue -- -- -- -- --
Total Revenue 19.72% 22.89% 19.85% 33.70% 25.07%
Cost of Revenue 6.90% 18.54% 21.37% 39.39% 20.75%
Gross Profit 21.39% 23.46% 19.67% 33.04% 25.65%
SG&A Expenses 25.32% 20.77% 36.62% 65.41% -14.81%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 5.80% 20.64% 39.53% 44.45% 15.30%
Operating Income 38.55% 24.83% 2.07% 25.28% 41.27%
Income Before Tax 34.22% 10.46% 6.00% 36.55% 65.21%
Income Tax Expenses 21.58% -5.58% 1.58% 80.39% 67.67%
Earnings from Continuing Operations 38.78% 15.51% 7.29% 27.27% 64.35%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 38.78% 15.51% 7.29% 27.27% 64.35%
EBIT 38.55% 24.83% 2.07% 25.28% 41.27%
EBITDA 38.81% 25.57% 3.77% 24.72% 38.77%
EPS Basic 45.93% 21.46% 13.33% 25.38% 60.15%
Normalized Basic EPS 57.13% 33.40% 11.56% 28.75% 111.36%
EPS Diluted 42.09% 18.77% 11.64% 26.95% 62.60%
Normalized Diluted EPS 52.82% 30.27% 10.06% 30.43% 115.16%
Average Basic Shares Outstanding -4.89% -4.90% -5.33% 1.51% 2.62%
Average Diluted Shares Outstanding -2.21% -2.62% -4.04% 0.20% 0.81%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings